The Valley Desk

NCT05883449 · Interventional trial

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Overall registry status Terminated

Phase 2

Conditions Peripheral T Cell Lymphoma, Relapsed or Refractory Hodgkin Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov